As of September 2024 Innate Pharma has a market cap of A$0.27 Billion. This makes Innate Pharma the world's 7872th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Sep 20th, 2024 the market cap of Innate Pharma was reported to be: